Genomic Health (NASDAQ:GHDX) reported Q4 2017 earnings this Morning, coming in at $0.05 per share, missing Wall Street’s estimates of $0.07 per Share. Revenue for the quarter came in at $87.50 million missing the streets estimates of $88.96 million Recent Insider Trading for Genomic Health (NASDAQ:GHDX)
- On 2/20/2018 G Bradley Cole, COO, sold 5,000 with an average share price of $32.89 per share and the total transaction amounting to $164,450.00.
- On 2/20/2018 Phillip G Febbo, Insider, sold 4,942 with an average share price of $32.84 per share and the total transaction amounting to $162,295.28.
- On 2/14/2018 Kimberly J Popovits, Insider, sold 10,000 with an average share price of $32.93 per share and the total transaction amounting to $329,300.00.
- On 1/16/2018 Kimberly J. Popovits, Insider, sold 10,000 with an average share price of $34.99 per share and the total transaction amounting to $349,900.00.
- On 1/9/2018 G Bradley Cole, COO, sold 5,000 with an average share price of $35.51 per share and the total transaction amounting to $177,550.00.
- On 1/2/2018 James J. Vaughn, Insider, sold 3,004 with an average share price of $34.09 per share and the total transaction amounting to $102,406.36.
Recent Trading for Genomic Health (NASDAQ:GHDX) Shares of Genomic Health closed the previous trading session at 33.25 +0.00 0.00% with 30.829999923706055 shares trading hands.